There are only few evidences that CD300A was found to be significantly overexpressed in hematological malignancies, such as acute lymphoblastic leukemia (ALL),26, 27 AML,28 and diffuse large B‐cell lymphoma (DLBCL).29 Here, CD300A is linked to acute myeloid leukemia.